Next Article in Journal
Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland
Next Article in Special Issue
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes
Previous Article in Journal
TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
Previous Article in Special Issue
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(5), 1216; https://doi.org/10.3390/cancers14051216
Action Date Notes Link
article pdf uploaded. 26 February 2022 08:10 CET Version of Record https://www.mdpi.com/2072-6694/14/5/1216/pdf-vor
article supplementary file uploaded. 26 February 2022 08:10 CET - https://www.mdpi.com/2072-6694/14/5/1216#supplementary
article xml file uploaded 28 February 2022 11:26 CET Original file -
article xml uploaded. 28 February 2022 11:26 CET Update https://www.mdpi.com/2072-6694/14/5/1216/xml
article pdf uploaded. 28 February 2022 11:26 CET Updated version of record https://www.mdpi.com/2072-6694/14/5/1216/pdf
article html file updated 28 February 2022 11:27 CET Original file -
article html file updated 1 August 2022 02:55 CEST Update https://www.mdpi.com/2072-6694/14/5/1216/html
Back to TopTop